Center for Scientific Review; Notice of Closed Meetings, 23989 [2014-09612]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 82 / Tuesday, April 29, 2014 / Notices
days of expiration of the budget/project
period.
sroberts on DSK5SPTVN1PROD with NOTICES
B. Financial Reports
Federal Financial Report FFR (SF–
425), Cash Transaction Reports are due
30 days after the close of every calendar
quarter to the Division of Payment
Management, HHS at: https://
www.dpm.psc.gov. It is recommended
that the applicant also send a copy of
the FFR (SF–425) report to the Grants
Management Specialist. Failure to
submit timely reports may cause a
disruption in timely payments to the
organization.
Grantees are responsible and
accountable for accurate information
being reported on all required reports:
the Progress Reports and Federal
Financial Report.
C. Federal Subaward Reporting System
(FSRS)
This award may be subject to the
Transparency Act subaward and
executive compensation reporting
requirements of 2 CFR part 170.
The Transparency Act requires the
OMB to establish a single searchable
database, accessible to the public, with
information on financial assistance
awards made by Federal agencies. The
Transparency Act also includes a
requirement for recipients of Federal
grants to report information about firsttier subawards and executive
compensation under Federal assistance
awards.
IHS has implemented a Term of
Award into all IHS Standard Terms and
Conditions, NoAs and funding
announcements regarding the FSRS
reporting requirement. This IHS Term of
Award is applicable to all IHS grant and
cooperative agreements issued on or
after October 1, 2010, with a $25,000
subaward obligation dollar threshold
met for any specific reporting period.
Additionally, all new (discretionary)
IHS awards (where the project period is
made up of more than one budget
period) and where: (1) The project
period start date was October 1, 2010 or
after and (2) the primary awardee will
have a $25,000 subaward obligation
dollar threshold during any specific
reporting period will be required to
address the FSRS reporting. For the full
IHS award term implementing this
requirement and additional award
applicability information, visit the
Grants Management Grants Policy Web
site at: https://www.ihs.gov/dgm/
index.cfm?module=dsp_dgm_
policy_topics.
Telecommunication for the hearing
impaired is available at: TTY (301) 443–
6394.
VerDate Mar<15>2010
16:56 Apr 28, 2014
Jkt 232001
VII. Agency Contacts
1. Questions on the programmatic issues
may be directed to: Jackie Santiago,
Office of Public Health Support, 801
Thompson Avenue, TMP Suite 450,
Rockville, Maryland 20852,
Telephone: (301) 443–2486, Fax: (301)
443–4815, Email:
Jackie.Santiago@ihs.gov.
2. Questions on grants management and
fiscal matters may be directed to:
Andrew Diggs, Grants Management
Specialist, 801 Thompson Avenue,
TMP Suite 360, Rockville, Maryland
20852, Phone: (301) 443–2262, Email:
Andrew.Diggs@ihs.gov.
3. Questions on systems matters may be
directed to: Paul Gettys, Grant
Systems Coordinator, 801 Thompson
Avenue, TMP Suite 360, Rockville,
MD 20852, Phone: (301) 443–2114; or
the DGM main line (301) 443–5204,
Fax: (301) 443–9602, E-Mail:
Paul.Gettys@ihs.gov.
VIII. Other Information
The Public Health Service strongly
encourages all grantees to provide a
smoke-free workplace and promote the
non-use of all tobacco products. In
addition, Public Law 103–227, the ProChildren Act of 1994, prohibits smoking
in certain facilities (or in some cases,
any portion of the facility) in which
regular or routine education, library,
day care, health care, or early childhood
development services are provided to
children. This is consistent with the
HHS mission to protect and advance the
physical and mental health of the
American people.
Dated: April 17, 2014.
Yvette Roubideaux,
Acting Director, Indian Health Service.
[FR Doc. 2014–09607 Filed 4–28–14; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
PO 00000
Frm 00062
Fmt 4703
Sfmt 9990
23989
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group; Synthetic and Biological
Chemistry B Study Section.
Date: May 29, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Washington DC,
Dupont Circle; 1143 New Hampshire Avenue
NW., Washington, DC 20037.
Contact Person: Kathryn M Koeller, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4166,
MSC 7806, Bethesda, MD 20892, 301–435
–2681, koellerk@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Chronic Dysfunction and Integrative
Neurodegeneration Study Section.
Date: May 29–30, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Alexei Kondratyev, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200,
MSC 7846, Bethesda, MD 20892, 301–435–
1785, kondratyevad@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; BD2K Data
Discovery Index Coordination Consortium
Panel.
Date: May 30, 2014.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Vonda K Smith, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6188,
MSC 7892, Bethesda, MD 20892, 301–435–
1789, smithvo@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 22, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–09612 Filed 4–28–14; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\29APN1.SGM
29APN1
]]>Agencies
[Federal Register Volume 79, Number 82 (Tuesday, April 29, 2014)]
[Notices]
[Page 23989]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-09612]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Biological Chemistry and Macromolecular
Biophysics Integrated Review Group; Synthetic and Biological
Chemistry B Study Section.
Date: May 29, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance Washington DC, Dupont Circle; 1143 New
Hampshire Avenue NW., Washington, DC 20037.
Contact Person: Kathryn M Koeller, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4166, MSC 7806, Bethesda, MD
20892, 301-435 -2681, koellerk@csr.nih.gov.
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group; Chronic Dysfunction and Integrative
Neurodegeneration Study Section.
Date: May 29-30, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Alexei Kondratyev, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD
20892, 301-435-1785, kondratyevad@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; BD2K Data Discovery Index Coordination Consortium Panel.
Date: May 30, 2014.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Vonda K Smith, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6188, MSC 7892, Bethesda, MD 20892, 301-435-
1789, smithvo@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: April 22, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-09612 Filed 4-28-14; 8:45 am]
BILLING CODE 4140-01-P
